Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
6
×
life sciences
national blog main
national top stories
new york blog main
6
×
boston top stories
san diego blog main
san diego top stories
san francisco blog main
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
eli lilly
fda
generic drugs
ipo
takeda pharmaceutical
armo biosciences
chemotherapy
drug prices
gene therapy
What
drugs
6
×
bio
roundup
pharmaceutical
public
adding
advance
ago
ahead
aiming
answer
appetite
asco
away
bails
balance
biology
black
brand
branded
bread
bridgebio
build
butter
buyout
cancer
capital
car
cash
choices
commissioner
company
consumers
costly
counterweight
cytokine
decibel
democratic
dems
develop
Language
unset
Current search:
drugs
×
cancer
×
" new york blog main "
×
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
